Profiling the Prognosis of Gastric Cancer Patients: Is It Worth Correlating the Survival with the Clinical/Pathological and Molecular Features of Gastric Cancers?
Figure 5
Gastric cancer and HER2 overexpression related survivals. (a) Overall survival, disease free survival and disease specific survival of gastric cancers according to the IHC scoring; (b) overall survival, disease free survival and disease specific survival analysis: negative tumors (HER2 0 and HER2 1+) versus equivocal/positive tumors (HER2 2+ and HER2 3+); (c) overall survival, disease free survival and disease specific survival: positive tumors (HER2 3+) versus other negative/equivocal tumors (HER2 0, HER2 1+, HER 2 2+).